Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Rheumatology (Oxford, England)|November 8, 2002
Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label studyM Breban, E Vignon, P Claudepierre, et al.Arthritis and Rheumatism|January 1, 2009
A case-control study to assess sensitivity and specificity of a questionnaire for the detection of hip and knee osteoarthritisJ Morvan, C H Roux, B Fautrel, et al.Osteoarthritis and Cartilage|August 31, 2011
Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based surveyF Guillemin, A C Rat, B Mazieres, et al.Annals of the Rheumatic Diseases|December 14, 2007
Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimatesC H Roux, A Saraux, B Mazieres, et al.Rheumatology (Oxford, England)|January 27, 2006
Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-upL Gossec, A Le Henanff, M Breban, et al.British Journal of Haematology|December 1, 1996
Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS)C Mathiot, J Y Mary, E Tartour, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 3, 1998
Human osteoclast formation and activity in vitro: effects of alendronateV Breuil, F Cosman, L Stein, et al.Annals of the Rheumatic Diseases|April 1, 2005
Prevalence of rheumatoid arthritis in France: 2001F Guillemin, A Saraux, P Guggenbuhl, et al.Annals of the Rheumatic Diseases|April 9, 2005
Prevalence of spondyloarthropathies in France: 2001A Saraux, F Guillemin, P Guggenbuhl, et al.British Journal of Haematology|November 25, 1998
VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85)P Mineur, J F Ménard, X Le Loët, et al.Pageof 5